Breaking News Instant updates and real-time market news.

GOOGL

Alphabet Class A

$1,191.79 /

-14.83 (-1.23%)

, GOOG

Alphabet

$1,196.00 /

-15.86 (-1.31%)

13:13
04/13/20
04/13
13:13
04/13/20
13:13

Apple and Google partner on COVID-19 contact tracing technology

Over the weekend, Apple (AAPL) and Google (GOOG:GOOGL) announced a partnership on COVID-19 contact tracing technology: The companies said, in part, in a joint statement : "Across the world, governments and health authorities are working together to find solutions to the COVID-19 pandemic, to protect people and get society back up and running. Software developers are contributing by crafting technical tools to help combat the virus and save lives. In this spirit of collaboration, Google and Apple are announcing a joint effort to enable the use of Bluetooth technology to help governments and health agencies reduce the spread of the virus, with user privacy and security central to the design. Since COVID-19 can be transmitted through close proximity to affected individuals, public health officials have identified contact tracing as a valuable tool to help contain its spread...First, in May, both companies will release APIs that enable interoperability between Android and iOS devices using apps from public health authorities. These official apps will be available for users to download via their respective app stores...Second, in the coming months, Apple and Google will work to enable a broader Bluetooth-based contact tracing platform by building this functionality into the underlying platforms. ..Privacy, transparency, and consent are of utmost importance in this effort, and we look forward to building this functionality in consultation with interested stakeholders. We will openly publish information about our work for others to analyze." Reference Link

GOOGL

Alphabet Class A

$1,191.79 /

-14.83 (-1.23%)

GOOG

Alphabet

$1,196.00 /

-15.86 (-1.31%)

AAPL

Apple

$268.29 /

+0.69 (+0.26%)

  • 20

    Apr

  • 30

    Apr

  • 14

    Sep

GOOGL Alphabet Class A
$1,191.79 /

-14.83 (-1.23%)

04/09/20 Loop Capital
Alphabet price target raised to $1400 from $1320 at Loop Capital
04/08/20 Deutsche Bank
Pinterest update shows Snap could post in-line Q1, says Deutsche Bank
04/08/20 Societe Generale
Alphabet price target lowered to $1,420 from $1,555 at Societe Generale
04/08/20 Piper Sandler
Netflix retakes lead in teen video share, Piper Sandler survey shows
GOOG Alphabet
$1,196.00 /

-15.86 (-1.31%)

04/07/20 Barclays
Alphabet price target lowered to $1,300 from $1,635 at Barclays
AAPL Apple
$268.29 /

+0.69 (+0.26%)

04/13/20 Raymond James
Apple price target lowered to $305 from $360 at Raymond James
04/13/20 Bernstein
Apple price target lowered to $285 from $300 at Bernstein
04/09/20 KeyBanc
KeyBanc remains cautious on Apple supply chain stocks, only recommends Broadcom
04/09/20 Nomura
Apple price target raised to $240 from $225 at Nomura Instinet

TODAY'S FREE FLY STORIES

Recommendations
Arcturus Therapeutics price target raised to $140 from $77 at Piper Sandler » 21:01
12/03/20
12/03
21:01
12/03/20
21:01
ARCT

Arcturus Therapeutics

$98.90 /

+15.86 (+19.10%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARCT Arcturus Therapeutics
$98.90 /

+15.86 (+19.10%)

ARCT Arcturus Therapeutics
$98.90 /

+15.86 (+19.10%)

11/11/20 B. Riley Securities
Arcturus Therapeutics price target lowered to $64 from $82 at B. Riley
11/09/20 Piper Sandler
Arcturus shares down on high expectations, says Piper Sandler
11/02/20 Piper Sandler
CureVac's positive vaccine data bodes well for Arcturus's ARCT-021, says Piper
10/06/20 Citi
Arcturus Therapeutics initiated with a Buy at Citi
ARCT Arcturus Therapeutics
$98.90 /

+15.86 (+19.10%)

  • 29
    Jul
  • 16
    Apr
ARCT Arcturus Therapeutics
$98.90 /

+15.86 (+19.10%)

ARCT Arcturus Therapeutics
$98.90 /

+15.86 (+19.10%)

Hot Stocks
BioCryst gets FDA approval for Orladeyo for treating hereditary angioedema » 20:50
12/03/20
12/03
20:50
12/03/20
20:50
BCRX

BioCryst

$5.14 /

+0.1 (+1.98%)

The company states:…

The company states: "BioCryst announced that the FDA has approved oral, once-daily ORLADEYO, or berotralstat, for prophylaxis to prevent attacks of hereditary angioedema in adults and pediatric patients 12 years and older. In the pivotal Phase 3 APeX-2 trial, ORLADEYO significantly reduced attacks at 24 weeks, and this reduction was sustained through 48 weeks. HAE patients who completed 48 weeks of treatment saw reductions in their HAE attack rates, from a mean of 2.9 attacks per month at baseline to a mean of 1.0 attacks per month after 48 weeks of therapy. In the long-term open label APeX-S trial, patients completing 48 weeks of therapy had a mean attack rate of 0.8 attacks per month. ORLADEYO was safe and well tolerated in both trials. The most frequently reported adverse reactions in patients receiving ORLADEYO compared with placebo were gastrointestinal reactions. These reactions generally occurred early after initiation of treatment with ORLADEYO, became less frequent with time and typically self-resolved. HAE patients note a significant treatment burden associated with existing prophylactic therapy. In addition to reducing HAE attack rate, data from APeX-2 show that patients reported meaningful improvements in both quality of life and overall patient-reported satisfaction, and significant reductions in their monthly use of standard of care on-demand medicine, while taking oral, once-daily ORLADEYO (150 mg)."

ShowHide Related Items >><<
BCRX BioCryst
$5.14 /

+0.1 (+1.98%)

BCRX BioCryst
$5.14 /

+0.1 (+1.98%)

11/23/20 Evercore ISI
BioCryst initiated with an Outperform at Evercore ISI
11/23/20 Evercore ISI
BioCryst initiated with an Outperform at Evercore ISI
11/05/20 Piper Sandler
Piper Sandler reiterates Overweight rating on BioCryst ahead of 'busy year-end'
09/30/20 Piper Sandler
Piper says BioCryst's early high dose 9930 data 'impressive'
BCRX BioCryst
$5.14 /

+0.1 (+1.98%)

  • 28
    May
BCRX BioCryst
$5.14 /

+0.1 (+1.98%)

BCRX BioCryst
$5.14 /

+0.1 (+1.98%)

Syndicate
Cambium Networks 2.5M share Secondary priced at $28.00 » 20:17
12/03/20
12/03
20:17
12/03/20
20:17
CMBM

Cambium Networks

$30.12 /

+0.79 (+2.69%)

The deal priced below the…

The deal priced below the last closing price of $30.13. JPMorgan is acting as lead book running manager for the offering.

ShowHide Related Items >><<
CMBM Cambium Networks
$30.12 /

+0.79 (+2.69%)

CMBM Cambium Networks
$30.12 /

+0.79 (+2.69%)

11/06/20 JPMorgan
Cambium Networks price target raised to $28 from $19 at JPMorgan
10/01/20 Northland
Cambium Networks initiated with an Outperform at Northland
09/17/20 JPMorgan
Cambium Networks price target raised to $19 from $16 at JPMorgan
08/12/20 Oppenheimer
Cambium Networks price target raised to $15 from $8 at Oppenheimer
CMBM Cambium Networks
$30.12 /

+0.79 (+2.69%)

  • 04
    Dec
CMBM Cambium Networks
$30.12 /

+0.79 (+2.69%)

Earnings
Afya reports Q3 net income R$101.2M, up 46.7% from last year » 20:15
12/03/20
12/03
20:15
12/03/20
20:15
AFYA

Afya

$25.29 /

-0.15 (-0.59%)

Reports Q3 revenue…

Reports Q3 revenue R$309.4M, up 49.7% from last year. CEO Virgilio Gibbon says: "I am pleased to report third quarter results, which were in line with expectations and the guidance we had provided. Earlier in the year, we had pivoted to leverage our online and virtual technology capabilities and adjust offerings for the Brazilian medical ecosystem. I am pleased that during the past quarter, across our medical schools, on site clinical classes are back. In turn, we were able to deliver H1 postponed classes and recognize the deferred revenue in the quarter. Additionally, our medical school maturation, successful integrations and execution, contributed to a 63% year over year increase in Adjusted EBITDA. Our liquidity was another highlight with a strong balance sheet to support acquisitions. We ended the quarter with R$1.1 billion in cash."

ShowHide Related Items >><<
AFYA Afya
$25.29 /

-0.15 (-0.59%)

AFYA Afya
$25.29 /

-0.15 (-0.59%)

10/19/20 JPMorgan
Afya downgraded to Neutral from Overweight at JPMorgan
09/27/20 Goldman Sachs
Afya upgraded to Buy from Neutral at Goldman Sachs
09/15/20 BofA
Afya reinstated with a Buy at BofA
05/20/20 UBS
Afya downgraded to Neutral from Buy at UBS
AFYA Afya
$25.29 /

-0.15 (-0.59%)

  • 07
    Feb
Hot Stocks
Francesca's files voluntary Chapter 11 to implement sale » 19:40
12/03/20
12/03
19:40
12/03/20
19:40
FRAN

Francesca's

$2.63 /

-0.02 (-0.75%)

Francesca's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FRAN Francesca's
$2.63 /

-0.02 (-0.75%)

FRAN Francesca's
$2.63 /

-0.02 (-0.75%)

FRAN Francesca's
$2.63 /

-0.02 (-0.75%)

Hot Stocks
Gol Linhas announces preliminary traffic figures for September » 19:38
12/03/20
12/03
19:38
12/03/20
19:38
GOL

Gol Linhas

$10.64 /

+0.99 (+10.26%)

the domestic market in…

the domestic market in November 2020, demand, or RPK, for GOL's flights was up by 5% over October 2020 and supply, or ASK, decreased by 3% over October 2020. GOL's domestic load factor was 84.5% in November. GOL did not operate regular international flights during the month.

ShowHide Related Items >><<
GOL Gol Linhas
$10.64 /

+0.99 (+10.26%)

GOL Gol Linhas
$10.64 /

+0.99 (+10.26%)

11/09/20 Seaport Global
Azul upgraded to Buy from Neutral at Seaport Global
10/13/20 Seaport Global
Gol Linhas upgraded to Buy after cost restructuring at Seaport Global
10/13/20 Seaport Global
Gol Linhas upgraded to Buy from Neutral at Seaport Global
09/30/20 Goldman Sachs
Azul, Gol Linhas, Volaris upgraded to Buy at Goldman Sachs
GOL Gol Linhas
$10.64 /

+0.99 (+10.26%)

GOL Gol Linhas
$10.64 /

+0.99 (+10.26%)

GOL Gol Linhas
$10.64 /

+0.99 (+10.26%)

Hot Stocks
Francesca's trading halted, news pending  19:34
12/03/20
12/03
19:34
12/03/20
19:34
FRAN

Francesca's

$2.63 /

-0.02 (-0.75%)

 
ShowHide Related Items >><<
FRAN Francesca's
$2.63 /

-0.02 (-0.75%)

FRAN Francesca's
$2.63 /

-0.02 (-0.75%)

FRAN Francesca's
$2.63 /

-0.02 (-0.75%)

Hot Stocks
SPDR Gold Shares holdings fall from 1,191.28MT to 1,189.82MT » 19:17
12/03/20
12/03
19:17
12/03/20
19:17
GLD

SPDR Gold Shares

$172.81 /

+1.31 (+0.76%)

This is the lowest level…

This is the lowest level of holdings since July 1st.

ShowHide Related Items >><<
GLD SPDR Gold Shares
$172.81 /

+1.31 (+0.76%)

GLD SPDR Gold Shares
$172.81 /

+1.31 (+0.76%)

GLD SPDR Gold Shares
$172.81 /

+1.31 (+0.76%)

GLD SPDR Gold Shares
$172.81 /

+1.31 (+0.76%)

Hot Stocks
Lemonade CFO sells 40K shares of common stock » 19:15
12/03/20
12/03
19:15
12/03/20
19:15
LMND

Lemonade

$80.16 /

+13.365 (+20.01%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LMND Lemonade
$80.16 /

+13.365 (+20.01%)

LMND Lemonade
$80.16 /

+13.365 (+20.01%)

11/23/20 Morgan Stanley
Root initiated with an Equal Weight at Morgan Stanley
11/12/20 Piper Sandler
Lemonade price target raised to $71 from $63 at Piper Sandler
11/02/20 Piper Sandler
Lemonade initiated with an Overweight at Piper Sandler
10/15/20
Fly Intel: Pre-market Movers
LMND Lemonade
$80.16 /

+13.365 (+20.01%)

  • 02
    Jul
LMND Lemonade
$80.16 /

+13.365 (+20.01%)

LMND Lemonade
$80.16 /

+13.365 (+20.01%)

Hot Stocks
LGI Homes reports 960 home closings in November » 19:04
12/03/20
12/03
19:04
12/03/20
19:04
LGIH

LGI Homes

$106.98 /

+4.39 (+4.28%)

LGI Homes announced 960…

LGI Homes announced 960 home closings in November 2020, up from 748 home closings in November 2019, representing year-over-year growth of 28.3%. In addition, the company ended the first eleven months of 2020 with 7,709 home closings, a 16.1% increase over 6,638 home closings during the first eleven months of 2019. As of the end of November 2020, the company had 114 active selling communities. "We are proud to announce another record breaking month of home closings," said Eric Lipar, Chief Executive Officer and Chairman of LGI Homes. "This was our best November on record and the second best month of closings overall in our history. Based on this outstanding November performance and our current view of the backlog available to close in December, we are updating our full year closings guidance to reflect our expectation of closing between 8,800 and 9,200 homes in 2020."

ShowHide Related Items >><<
LGIH LGI Homes
$106.98 /

+4.39 (+4.28%)

LGIH LGI Homes
$106.98 /

+4.39 (+4.28%)

11/17/20 JPMorgan
LGI Homes downgraded to Underweight from Neutral at JPMorgan
11/17/20 JPMorgan
LGI Homes downgraded to Underweight from Neutral at JPMorgan
11/06/20 JMP Securities
LGI Homes price target raised to $140 from $125 at JMP Securities
10/08/20 JPMorgan
LGI Homes price target raised to $140 from $122 at JPMorgan
LGIH LGI Homes
$106.98 /

+4.39 (+4.28%)

Hot Stocks
Azek CEO: We felt really good about the quarter » 18:51
12/03/20
12/03
18:51
12/03/20
18:51
AZEK

Azek

$34.71 /

-0.92 (-2.58%)

On an interview on…

On an interview on CNBC's Mad Money, Jesse Singh said, "We had a really strong quarter that capped off a strong year." Azek is seeing good trends in the remodel business, Singh noted. The company is only playing in 20% of the market, leaving a huge runway ahead, he added. The single largest raw material Azek uses is recycled plastics. That is giving the company a huge cost advantage versus using virgin product, Singh said.

ShowHide Related Items >><<
AZEK Azek
$34.71 /

-0.92 (-2.58%)

AZEK Azek
$34.71 /

-0.92 (-2.58%)

11/12/20 BofA
Azek downgraded to Underperform from Neutral at BofA
10/13/20 Stifel
Azek resumed with a Buy at Stifel
09/30/20 Goldman Sachs
Azek upgraded to Conviction Buy from Neutral at Goldman Sachs
08/20/20 Barclays
Azek price target raised to $44 from $42 at Barclays
AZEK Azek
$34.71 /

-0.92 (-2.58%)

  • 11
    Sep
  • 12
    Jun
AZEK Azek
$34.71 /

-0.92 (-2.58%)

AZEK Azek
$34.71 /

-0.92 (-2.58%)

AZEK Azek
$34.71 /

-0.92 (-2.58%)

Periodicals
Tesla reportedly skips battery testing for Chinese-made Model 3, Inside EVs says » 18:44
12/03/20
12/03
18:44
12/03/20
18:44
TSLA

Tesla

$593.10 /

+24.42 (+4.29%)

Tesla's has…

Tesla's has reportedly foregone battery testing for its LFP-powered Model 3 vehicle in China, Inside EVs' Gustavo Henrique Ruffo reports, citing Chinese website Sina Finance. The Sina article described a Model 3 owner that claimed the energy density range dropped from the 420 km it used to show to 241 km with only 5% of charge left. Reference Link

ShowHide Related Items >><<
TSLA Tesla
$593.10 /

+24.42 (+4.29%)

TSLA Tesla
$593.10 /

+24.42 (+4.29%)

12/03/20
Fly Intel: Top five analyst upgrades
12/02/20 Goldman Sachs
Tesla upgraded to Buy from Neutral at Goldman Sachs
11/27/20 BofA
BofA positive on long-term share gains for NIO Inc. after hosting calls
11/18/20
Fly Intel: Top five analyst upgrades
TSLA Tesla
$593.10 /

+24.42 (+4.29%)

  • 14
    Feb
TSLA Tesla
$593.10 /

+24.42 (+4.29%)

TSLA Tesla
$593.10 /

+24.42 (+4.29%)

TSLA Tesla
$593.10 /

+24.42 (+4.29%)

Periodicals
U.S. in talks with Huawei CFO to settle charges, WSJ reports » 18:40
12/03/20
12/03
18:40
12/03/20
18:40
MU

Micron

$69.91 /

+0.81 (+1.17%)

, WDC

Western Digital

$48.48 /

+0.76 (+1.59%)

, ACIA

Acacia Communications

$70.02 /

-0.11 (-0.16%)

, NPTN

NeoPhotonics

$8.27 /

+0.06 (+0.73%)

, LITE

Lumentum

$87.87 /

+0.71 (+0.81%)

, IIVI

II-VI

$68.98 /

-0.73 (-1.05%)

The U.S. Department of…

The U.S. Department of Justice is in talks over a deal with Meng Wanzhou, CFO of China's Huawei, that would allow her to return home to China from Canada in exchange for admitting wrongdoing in a criminal case that has strained China's relations with the U.S. and Canada, the Wall Street Journal's Jacquie McNish, Aruna Viswanatha, Jonathan Cheng, and Dan Strumpf report, citing people familiar with the matter. Huawei suppliers include Micron Technology (MU) and Western Digital (WDC), while makers of optical components, including Acacia Communications (ACIA), NeoPhotonics (NPTN), Lumentum (LITE), and Finisar (IIVI), have previously reacted negatively to headlines regarding enforcement actions and allegations against China's Huawei. Reference Link

ShowHide Related Items >><<
WDC Western Digital
$48.48 /

+0.76 (+1.59%)

NPTN NeoPhotonics
$8.27 /

+0.06 (+0.73%)

MU Micron
$69.91 /

+0.81 (+1.17%)

LITE Lumentum
$87.87 /

+0.71 (+0.81%)

IIVI II-VI
$68.98 /

-0.73 (-1.05%)

ACIA Acacia Communications
$70.02 /

-0.11 (-0.16%)

MU Micron
$69.91 /

+0.81 (+1.17%)

12/03/20 Mizuho
Micron's 'brief' outage could add to DRAM shortages, says Mizuho
12/03/20 Wells Fargo
Micron's DRAM fab in Taiwan reported to experience outage, says Wells Fargo
12/02/20 Morgan Stanley
Micron price target raised to $68 from $63 at Morgan Stanley
12/02/20 Deutsche Bank
Micron price target raised to $75 from $70 at Deutsche Bank
WDC Western Digital
$48.48 /

+0.76 (+1.59%)

10/29/20 Mizuho
Western Digital price target lowered to $57 from $62 at Mizuho
10/19/20 Lynx
Intel/SK Hynix deal impact to Western, Micron 'manageable,' says Lynx
ACIA Acacia Communications
$70.02 /

-0.11 (-0.16%)

NPTN NeoPhotonics
$8.27 /

+0.06 (+0.73%)

11/06/20
Fly Intel: Top five analyst initiations
11/06/20 MKM Partners
NeoPhotonics assumed with a Buy at MKM Partners
11/05/20 Needham
NeoPhotonics upgraded to Buy from Hold at Needham
11/05/20 Needham
NeoPhotonics upgraded to Buy from Hold at Needham
LITE Lumentum
$87.87 /

+0.71 (+0.81%)

11/06/20 MKM Partners
Lumentum assumed with a Buy at MKM Partners
11/03/20 JPMorgan
Lumentum price target raised to $100 from $97 at JPMorgan
10/19/20 Northland
Fabrinet upgraded to Outperform following pullback at Northland
IIVI II-VI
$68.98 /

-0.73 (-1.05%)

11/06/20 Canaccord
II-VI price target raised to $86 from $67 at Canaccord
11/06/20 JPMorgan
II-VI price target raised to $65 from $51 at JPMorgan
11/06/20 Deutsche Bank
II-VI price target raised to $63 from $58 at Deutsche Bank
11/06/20 Citi
II-VI price target raised to $65 from $53 at Citi
WDC Western Digital
$48.48 /

+0.76 (+1.59%)

NPTN NeoPhotonics
$8.27 /

+0.06 (+0.73%)

MU Micron
$69.91 /

+0.81 (+1.17%)

LITE Lumentum
$87.87 /

+0.71 (+0.81%)

IIVI II-VI
$68.98 /

-0.73 (-1.05%)

ACIA Acacia Communications
$70.02 /

-0.11 (-0.16%)

  • 02
    Jul
WDC Western Digital
$48.48 /

+0.76 (+1.59%)

NPTN NeoPhotonics
$8.27 /

+0.06 (+0.73%)

MU Micron
$69.91 /

+0.81 (+1.17%)

ACIA Acacia Communications
$70.02 /

-0.11 (-0.16%)

WDC Western Digital
$48.48 /

+0.76 (+1.59%)

NPTN NeoPhotonics
$8.27 /

+0.06 (+0.73%)

MU Micron
$69.91 /

+0.81 (+1.17%)

LITE Lumentum
$87.87 /

+0.71 (+0.81%)

IIVI II-VI
$68.98 /

-0.73 (-1.05%)

ACIA Acacia Communications
$70.02 /

-0.11 (-0.16%)

WDC Western Digital
$48.48 /

+0.76 (+1.59%)

MU Micron
$69.91 /

+0.81 (+1.17%)

LITE Lumentum
$87.87 /

+0.71 (+0.81%)

On The Fly
Fly Intel: After-Hours Movers » 18:33
12/03/20
12/03
18:33
12/03/20
18:33
PD

PagerDuty

$32.33 /

-1.93 (-5.63%)

, CLDR

Cloudera

$11.58 /

+0.37 (+3.30%)

, DOMO

Domo

$38.35 /

+1.45 (+3.93%)

, ZUO

Zuora

$11.77 /

+0.18 (+1.55%)

, DOCU

DocuSign

$231.09 /

+13.52 (+6.21%)

, SWBI

Smith & Wesson Brands

$15.14 /

-0.33 (-2.13%)

, STRO

Sutro Biopharma

$17.01 /

+0.66 (+4.04%)

, KRA

Kraton

$27.84 /

-0.675 (-2.37%)

, CGNX

Cognex

$74.63 /

-1.36 (-1.79%)

, YEXT

Yext

$19.31 /

+0.6 (+3.21%)

, OLLI

Ollie's Bargain Outlet

$89.54 /

+2.7 (+3.11%)

, TLYS

Tilly's

$9.37 /

+0.57 (+6.48%)

, MRVL

Marvell

$45.48 /

-0.12 (-0.26%)

, MDLA

Medallia

$35.21 /

+1.415 (+4.19%)

, ULTA

Ulta Beauty

$289.51 /

+7.8 (+2.77%)

, RCL

Royal Caribbean

$84.41 /

+3.76 (+4.66%)

Check out this evening's…

ShowHide Related Items >><<
ZUO Zuora
$11.77 /

+0.18 (+1.55%)

YEXT Yext
$19.31 /

+0.6 (+3.21%)

ULTA Ulta Beauty
$289.51 /

+7.8 (+2.77%)

TLYS Tilly's
$9.37 /

+0.57 (+6.48%)

SWBI Smith & Wesson Brands
$15.14 /

-0.33 (-2.13%)

STRO Sutro Biopharma
$17.01 /

+0.66 (+4.04%)

RCL Royal Caribbean
$84.41 /

+3.76 (+4.66%)

PD PagerDuty
$32.33 /

-1.93 (-5.63%)

OLLI Ollie's Bargain Outlet
$89.54 /

+2.7 (+3.11%)

MRVL Marvell
$45.48 /

-0.12 (-0.26%)

MDLA Medallia
$35.21 /

+1.415 (+4.19%)

KRA Kraton
$27.84 /

-0.675 (-2.37%)

DOCU DocuSign
$231.09 /

+13.52 (+6.21%)

CLDR Cloudera
$11.58 /

+0.37 (+3.30%)

CGNX Cognex
$74.63 /

-1.36 (-1.79%)

PD PagerDuty
$32.33 /

-1.93 (-5.63%)

11/30/20 Craig-Hallum
Craig-Hallum bullish on PagerDuty, initiates with a Buy
11/30/20 Craig-Hallum
PagerDuty initiated with a Buy at Craig-Hallum
11/17/20 Credit Suisse
PagerDuty initiated with a Neutral at Credit Suisse
10/07/20
Fly Intel: Top five analyst initiations
CLDR Cloudera
$11.58 /

+0.37 (+3.30%)

09/03/20 Northland
Cloudera price target raised to $13 from $11 at Northland
09/03/20 Barclays
Cloudera price target raised to $13 from $10 at Barclays
06/10/20 Morgan Stanley
Morgan Stanley says Cloudera could be valued at $14.50 using typical PE multiple
06/09/20 DA Davidson
DA Davidson says Cloudera sale 'increasingly likely,' IBM seen as possible buyer
DOMO Domo
$38.35 /

+1.45 (+3.93%)

09/04/20 Needham
Domo price target raised to $61 from $47 at Needham
09/04/20 Cowen
Domo price target raised to $50 from $42 at Cowen
09/04/20 Credit Suisse
Domo price target raised to $40 from $33 at Credit Suisse
09/04/20 Morgan Stanley
Domo's vision may be 'starting to resonate,' says Morgan Stanley
ZUO Zuora
$11.77 /

+0.18 (+1.55%)

06/29/20 Goldman Sachs
Zuora price target raised to $11 from $10 at Goldman Sachs
06/16/20 Northland
Zuora initiated with a Market Perform at Northland
06/04/20 Canaccord
Zuora price target raised to $19 from $15 at Canaccord
06/04/20 Jefferies
Zuora price target raised to $15 from $11 at Jefferies
DOCU DocuSign
$231.09 /

+13.52 (+6.21%)

11/30/20 Baird
DocuSign Q3results expected to show another strong quarter, says Baird
11/23/20 Citi
DocuSign price target raised to $257 from $250 at Citi
11/18/20
Fly Intel: Top five analyst initiations
11/18/20 Needham
DocuSign initiated with a Buy at Needham
SWBI Smith & Wesson Brands
$15.14 /

-0.33 (-2.13%)

10/05/20 B. Riley Securities
Firearm demand has seen meaningful uptick, says B. Riley Securities
09/24/20
Fly Intel: Top five analyst initiations
09/24/20 Aegis
Smith & Wesson Brands initiated with a Buy at Aegis
09/24/20 Aegis
Smith & Wesson Brands initiated with a Buy at Aegis
STRO Sutro Biopharma
$17.01 /

+0.66 (+4.04%)

12/02/20 Stifel
Sutro Biopharma initiated with a Buy at Stifel
11/06/20 Piper Sandler
Sutro Biopharma price target raised to $22 from $20 at Piper Sandler
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/02/20 Jefferies
Sutro Biopharma initiated with a Buy at Jefferies
KRA Kraton
$27.84 /

-0.675 (-2.37%)

10/19/20 Truist
Truist raises price targets in select Chemicals names
10/16/20 Loop Capital
Kraton price target raised to $45 from $29 at Loop Capital
10/09/20 Truist
Kraton price target raised to $30 from $25 at Truist
10/06/20 Truist
Kraton price target raised to $25 from $20 at Truist
CGNX Cognex
$74.63 /

-1.36 (-1.79%)

10/30/20 Baird
Cognex upgraded to Neutral from Underperform at Baird
10/16/20 Stephens
Cognex initiated with an Overweight at Stephens
09/04/20 Daiwa
Cognex downgraded to Neutral from Outperform at Daiwa
08/25/20 Wolfe Research
Cognex initiated with an Underperform at Wolfe Research
YEXT Yext
$19.31 /

+0.6 (+3.21%)

07/09/20 Needham
Yext price target raised to $21 from $19 at Needham
06/25/20 MKM Partners
Yext initiated with a Buy at MKM Partners
06/24/20 MKM Partners
Yext initiated with a Buy at MKM Partners
06/23/20 William Blair
Yext initiated with an Outperform at William Blair
OLLI Ollie's Bargain Outlet
$89.54 /

+2.7 (+3.11%)

11/18/20 Berenberg
Ollie's Bargain Outlet initiated with a Hold at Berenberg
11/02/20
Fly Intel: Top five analyst downgrades
11/02/20 Wells Fargo
Ollie's Bargain Outlet downgraded to Underweight from Overweight at Wells Fargo
08/28/20 Craig-Hallum
Ollie's Bargain Outlet price target raised to $128 from $120 at Craig-Hallum
TLYS Tilly's
$9.37 /

+0.57 (+6.48%)

09/04/20 Roth Capital
Tilly's reports 'solid' Q2 earnings beat, says Roth Capital
09/04/20 B. Riley Securities
Tilly's price target raised to $10 from $9 at B. Riley FBR
01/14/20 Pivotal Research
Tilly's downgraded to Hold from Buy at Pivotal Research
01/14/20 Pivotal Research
Tilly's downgraded to Hold from Buy at Pivotal Research
MRVL Marvell
$45.48 /

-0.12 (-0.26%)

12/01/20 Susquehanna
Marvell price target raised to $54 from $50 at Susquehanna
11/30/20 B. Riley Securities
Marvell price target raised to $55 from $48 at B. Riley Securities
11/19/20 Citi
Citi moves Lam Research, Marvell to top picks in Semi Equipment
11/04/20 KeyBanc
KeyBanc lays out possible M&A candidates as semi consolidation heats ups
MDLA Medallia
$35.21 /

+1.415 (+4.19%)

10/05/20 BTIG
Medallia initiated with a Buy at BTIG
09/24/20 Oppenheimer
Medallia recent selloff looks overdone, says Oppenheimer
09/04/20 Truist
Medallia price target raised to $39 from $33 at Truist
09/04/20 Roth Capital
Medallia positioned for further growth, says Roth Capital
ULTA Ulta Beauty
$289.51 /

+7.8 (+2.77%)

11/30/20 JPMorgan
Ulta Beauty price target raised to $330 from $260 at JPMorgan
11/24/20
Fly Intel: Top five analyst downgrades
11/24/20 OTR Global
Ulta Beauty upgraded to Mixed from Negative at OTR Global
11/24/20 Jefferies
Jefferies downgrades Ulta Beauty to Hold after holiday spending survey
RCL Royal Caribbean
$84.41 /

+3.76 (+4.66%)

10/30/20 Stifel
CDC lifting 'no sail order' a 'clear positive' for cruise liners, says Stifel
10/30/20 Deutsche Bank
Royal Caribbean price target raised to $46 from $43 at Deutsche Bank
10/16/20 Deutsche Bank
Deutsche sees Covid newsflow remaining drag on cruise stocks
10/15/20 Berenberg
Royal Caribbean price target raised to $60 from $45 at Berenberg
ZUO Zuora
$11.77 /

+0.18 (+1.55%)

YEXT Yext
$19.31 /

+0.6 (+3.21%)

ULTA Ulta Beauty
$289.51 /

+7.8 (+2.77%)

TLYS Tilly's
$9.37 /

+0.57 (+6.48%)

SWBI Smith & Wesson Brands
$15.14 /

-0.33 (-2.13%)

STRO Sutro Biopharma
$17.01 /

+0.66 (+4.04%)

RCL Royal Caribbean
$84.41 /

+3.76 (+4.66%)

PD PagerDuty
$32.33 /

-1.93 (-5.63%)

OLLI Ollie's Bargain Outlet
$89.54 /

+2.7 (+3.11%)

MRVL Marvell
$45.48 /

-0.12 (-0.26%)

MDLA Medallia
$35.21 /

+1.415 (+4.19%)

KRA Kraton
$27.84 /

-0.675 (-2.37%)

DOMO Domo
$38.35 /

+1.45 (+3.93%)

DOCU DocuSign
$231.09 /

+13.52 (+6.21%)

CLDR Cloudera
$11.58 /

+0.37 (+3.30%)

CGNX Cognex
$74.63 /

-1.36 (-1.79%)

  • 14
    Oct
  • 12
    May
ULTA Ulta Beauty
$289.51 /

+7.8 (+2.77%)

SWBI Smith & Wesson Brands
$15.14 /

-0.33 (-2.13%)

RCL Royal Caribbean
$84.41 /

+3.76 (+4.66%)

MRVL Marvell
$45.48 /

-0.12 (-0.26%)

DOCU DocuSign
$231.09 /

+13.52 (+6.21%)

CLDR Cloudera
$11.58 /

+0.37 (+3.30%)

ZUO Zuora
$11.77 /

+0.18 (+1.55%)

YEXT Yext
$19.31 /

+0.6 (+3.21%)

ULTA Ulta Beauty
$289.51 /

+7.8 (+2.77%)

SWBI Smith & Wesson Brands
$15.14 /

-0.33 (-2.13%)

STRO Sutro Biopharma
$17.01 /

+0.66 (+4.04%)

RCL Royal Caribbean
$84.41 /

+3.76 (+4.66%)

PD PagerDuty
$32.33 /

-1.93 (-5.63%)

OLLI Ollie's Bargain Outlet
$89.54 /

+2.7 (+3.11%)

MRVL Marvell
$45.48 /

-0.12 (-0.26%)

KRA Kraton
$27.84 /

-0.675 (-2.37%)

DOMO Domo
$38.35 /

+1.45 (+3.93%)

DOCU DocuSign
$231.09 /

+13.52 (+6.21%)

CLDR Cloudera
$11.58 /

+0.37 (+3.30%)

ZUO Zuora
$11.77 /

+0.18 (+1.55%)

ULTA Ulta Beauty
$289.51 /

+7.8 (+2.77%)

SWBI Smith & Wesson Brands
$15.14 /

-0.33 (-2.13%)

STRO Sutro Biopharma
$17.01 /

+0.66 (+4.04%)

RCL Royal Caribbean
$84.41 /

+3.76 (+4.66%)

PD PagerDuty
$32.33 /

-1.93 (-5.63%)

MRVL Marvell
$45.48 /

-0.12 (-0.26%)

DOMO Domo
$38.35 /

+1.45 (+3.93%)

DOCU DocuSign
$231.09 /

+13.52 (+6.21%)

CLDR Cloudera
$11.58 /

+0.37 (+3.30%)

Periodicals
Top Google AI researcher says she was fired over email, TechCrunch says » 18:30
12/03/20
12/03
18:30
12/03/20
18:30
GOOG

Alphabet

$1,827.70 /

-0.17 (-0.01%)

, GOOGL

Alphabet Class A

$1,823.88 /

-2.62 (-0.14%)

Timnit Gebru, top…

Timnit Gebru, top researcher and voice in the field of ethics and AI, is claiming that Google fired her for an email she sent to her direct subordinates, TechCrunch's Megan Rose Dickey reports. Gebru said that Google fired her because of an email she sent to reports that the company alleged reflected "behavior that is inconsistent with the expectations of a Google manager," the author says. Reference Link

ShowHide Related Items >><<
GOOGL Alphabet Class A
$1,823.88 /

-2.62 (-0.14%)

GOOG Alphabet
$1,827.70 /

-0.17 (-0.01%)

GOOG Alphabet
$1,827.70 /

-0.17 (-0.01%)

11/27/20 Truist
Amazon to claim 42c of every e-commerce dollar spent, says Truist
11/19/20 Keefe Bruyette
Too early to know if new Google Pay is PayPal, Square threat, says KBW
11/03/20 Citi
Alphabet Class A price target raised to $2,000 from $1,600 at Citi
11/02/20 Canaccord
Alphabet price target raised to $1900 from $1800 at Canaccord
GOOGL Alphabet Class A
$1,823.88 /

-2.62 (-0.14%)

11/27/20 MKM Partners
Facebook, Google may also be interested in Slack, says MKM Partners
11/23/20 KeyBanc
Slack Technologies initiated with a Sector Weight at KeyBanc
GOOGL Alphabet Class A
$1,823.88 /

-2.62 (-0.14%)

GOOG Alphabet
$1,827.70 /

-0.17 (-0.01%)

GOOG Alphabet
$1,827.70 /

-0.17 (-0.01%)

GOOG Alphabet
$1,827.70 /

-0.17 (-0.01%)

GOOGL Alphabet Class A
$1,823.88 /

-2.62 (-0.14%)

GOOG Alphabet
$1,827.70 /

-0.17 (-0.01%)

Syndicate
Royal Caribbean files to sell $1B shares of common stock at-the-market » 18:30
12/03/20
12/03
18:30
12/03/20
18:30
RCL

Royal Caribbean

$84.41 /

+3.76 (+4.66%)

Managers include: BofA…

Managers include: BofA Securities, Citigroup, Goldman Sachs & Co., J.P. Morgan, Morgan Stanley, BBVA, BNP PARIBAS, BTIG, COMMERZBANK, DNB Markets, Fifth Third Securities, HSBC, Mizuho Securities, MUFG, PNC Capital Markets, R. Seelaus & Co., Santander, Scotiabank, SEB, SMBC Nikko, SOCIETE GENERAL, Truist Securities.

ShowHide Related Items >><<
RCL Royal Caribbean
$84.41 /

+3.76 (+4.66%)

RCL Royal Caribbean
$84.41 /

+3.76 (+4.66%)

10/30/20 Stifel
CDC lifting 'no sail order' a 'clear positive' for cruise liners, says Stifel
10/30/20 Deutsche Bank
Royal Caribbean price target raised to $46 from $43 at Deutsche Bank
10/16/20 Deutsche Bank
Deutsche sees Covid newsflow remaining drag on cruise stocks
10/15/20 Berenberg
Royal Caribbean price target raised to $60 from $45 at Berenberg
RCL Royal Caribbean
$84.41 /

+3.76 (+4.66%)

  • 14
    Oct
RCL Royal Caribbean
$84.41 /

+3.76 (+4.66%)

RCL Royal Caribbean
$84.41 /

+3.76 (+4.66%)

RCL Royal Caribbean
$84.41 /

+3.76 (+4.66%)

Conference/Events
Goldman Sachs to hold global macro equity monthly conference call » 18:25
12/03/20
12/03
18:25
12/03/20
18:25

Senior Markets Advisor…

Senior Markets Advisor Wilson, Chief US Equity Strategist Kostin and Head of Global Equities Asia Moizant hold a monthly macro and markets Analyst/Industry conference call to be held on December 2 at 7 pm. Webcast Link

Hot Stocks
Kraton jumps over 7% after $50M extension to credit facility » 18:24
12/03/20
12/03
18:24
12/03/20
18:24
KRA

Kraton

$27.84 /

-0.675 (-2.37%)

Shares of Kraton are up…

Shares of Kraton are up 7.7% to $30 after announcing a $50M extension to its credit facility. The company states: "Kraton announced that it has entered into an amendment to its senior secured asset-based revolving credit facility, or "ABL Facility". The amendment extends the maturity date of the ABL Facility from January 2023 to December 2025 and provides for a $50 million increase in aggregate commitment to $300 million."

ShowHide Related Items >><<
KRA Kraton
$27.84 /

-0.675 (-2.37%)

KRA Kraton
$27.84 /

-0.675 (-2.37%)

10/19/20 Truist
Truist raises price targets in select Chemicals names
10/16/20 Loop Capital
Kraton price target raised to $45 from $29 at Loop Capital
10/09/20 Truist
Kraton price target raised to $30 from $25 at Truist
10/06/20 Truist
Kraton price target raised to $25 from $20 at Truist
KRA Kraton
$27.84 /

-0.675 (-2.37%)

KRA Kraton
$27.84 /

-0.675 (-2.37%)

Hot Stocks
American Eagle reinstates 13.75c per share quarterly dividend » 18:19
12/03/20
12/03
18:19
12/03/20
18:19
AEO

American Eagle

$18.89 /

+0.535 (+2.91%)

American Eagle announced…

American Eagle announced that its board has updated the record and payment dates of the previously-deferred first quarter 2020 cash dividend, which originally was declared on March 26, 2020 and deferred on April 2, 2020 in response to store closures resulting from the COVID-19 pandemic. The $0.1375 per share cash dividend is now payable on December 30, 2020 to stockholders of record at the close of business on December 16, 2020.

ShowHide Related Items >><<
AEO American Eagle
$18.89 /

+0.535 (+2.91%)

AEO American Eagle
$18.89 /

+0.535 (+2.91%)

11/27/20 RBC Capital
American Eagle price target raised to $19 from $14 at RBC Capital
11/25/20 Jefferies
American Eagle price target raised to $22 from $20 at Jefferies
11/25/20 B. Riley Securities
American Eagle price target raised to $20 from $19 at B. Riley Securities
11/25/20 Raymond James
American Eagle price target raised to $20 from $15 at Raymond James
AEO American Eagle
$18.89 /

+0.535 (+2.91%)

AEO American Eagle
$18.89 /

+0.535 (+2.91%)

AEO American Eagle
$18.89 /

+0.535 (+2.91%)

AEO American Eagle
$18.89 /

+0.535 (+2.91%)

Upgrade
Fraport upgraded to Buy from Hold at Deutsche Bank » 18:18
12/03/20
12/03
18:18
12/03/20
18:18
FPRUY

Fraport

$0.00 /

+ (+0.00%)

Deutsche Bank analyst…

Deutsche Bank analyst Siobhan Lynch upgraded Fraport to Buy from Hold with a price target of EUR 60, up from EUR 35. The analyst cites the 38% year-to-date decline in the stock price, with the company lagging its peers. Lynch adds that although Fraport has more significant exposure to business travel than other European airport operators, she also believes that the market and management guidance on the traffic recovery continues to be "too conservative".

ShowHide Related Items >><<
FPRUY Fraport
$0.00 /

+ (+0.00%)

12/01/20 HSBC
Fraport downgraded to Hold from Buy at HSBC
12/01/20 HSBC
Fraport downgraded to Hold from Buy at HSBC
11/25/20 Morgan Stanley
Fraport price target lowered to EUR 54 from EUR 74 at Morgan Stanley
11/13/20 JPMorgan
Fraport upgraded to Neutral from Underweight at JPMorgan
Hot Stocks
TTEC Holdings declares special, one-time cash dividend of $2.14 per share » 17:58
12/03/20
12/03
17:58
12/03/20
17:58
TTEC

TTEC Holdings

$69.61 /

+2.03 (+3.00%)

The dividend is payable…

The dividend is payable on December 30 to shareholders of record as of December 18.

ShowHide Related Items >><<
TTEC TTEC Holdings
$69.61 /

+2.03 (+3.00%)

TTEC TTEC Holdings
$69.61 /

+2.03 (+3.00%)

10/15/20 Canaccord
TTEC Holdings model steadily shifts to digital, Canaccord starts with a Buy
10/15/20 Canaccord
TTEC Holdings initiated with a Buy at Canaccord
08/10/20
Fly Intel: Top five analyst downgrades
08/10/20 Sidoti
TTEC Holdings downgraded to Neutral from Buy at Sidoti
TTEC TTEC Holdings
$69.61 /

+2.03 (+3.00%)

  • 06
    Dec
Conference/Events
Washington Prime to host business news update conference call » 17:58
12/03/20
12/03
17:58
12/03/20
17:58
WPG

Washington Prime

$1.13 /

+0.005 (+0.45%)

CEO Conforti holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WPG Washington Prime
$1.13 /

+0.005 (+0.45%)

WPG Washington Prime
$1.13 /

+0.005 (+0.45%)

12/01/20 Compass Point
Compass Point upgrades Washington Prime to Buy amid bankruptcy fears
11/30/20 Compass Point
Washington Prime upgraded to Buy from Neutral at Compass Point
06/04/20 Compass Point
Compass Point starts Washington Prime with Neutral, $1 price target
06/04/20 Compass Point
Washington Prime initiated with a Neutral at Compass Point
WPG Washington Prime
$1.13 /

+0.005 (+0.45%)

Conference/Events
VBI Vaccines participates in a conference call with Raymond James » 17:52
12/03/20
12/03
17:52
12/03/20
17:52
VBIV

VBI Vaccines

$3.14 /

-0.1 (-3.09%)

Biotechnology Analyst…

Biotechnology Analyst Seedhouse holds a conference call with CEO Baxter & Chief Scientific Officer Anderson to discuss the strategic outlook for the Company's Hepatitis B (HBV) portfolio on December 8 at 11 am. Webcast Link

ShowHide Related Items >><<
VBIV VBI Vaccines
$3.14 /

-0.1 (-3.09%)

VBIV VBI Vaccines
$3.14 /

-0.1 (-3.09%)

08/27/20 Raymond James
VBI Vaccines upgraded to Strong Buy from Outperform at Raymond James
08/27/20 Oppenheimer
VBI Vaccines' COVID vaccine has potential to be best-in-class, says Oppenheimer
08/26/20 Raymond James
VBI Vaccines upgraded to Strong Buy from Outperform at Raymond James
06/23/20 Oppenheimer
VBI Vaccines price target raised to $8 from $5 at Oppenheimer
  • 22
    Apr
VBIV VBI Vaccines
$3.14 /

-0.1 (-3.09%)

VBIV VBI Vaccines
$3.14 /

-0.1 (-3.09%)

Conference/Events
Intuit to host conference call » 17:47
12/03/20
12/03
17:47
12/03/20
17:47
INTU

Intuit

$363.69 /

+8.21 (+2.31%)

Management holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INTU Intuit
$363.69 /

+8.21 (+2.31%)

INTU Intuit
$363.69 /

+8.21 (+2.31%)

11/20/20 Morgan Stanley
Intuit price target raised to $455 from $400 at Morgan Stanley
11/20/20 Oppenheimer
Intuit price target raised to $382 from $355 at Oppenheimer
11/20/20 Wells Fargo
Intuit price target raised to $400 from $380 at Wells Fargo
11/20/20 RBC Capital
Intuit price target raised to $415 from $405 at RBC Capital
INTU Intuit
$363.69 /

+8.21 (+2.31%)

INTU Intuit
$363.69 /

+8.21 (+2.31%)

INTU Intuit
$363.69 /

+8.21 (+2.31%)

INTU Intuit
$363.69 /

+8.21 (+2.31%)

Hot Stocks
Zogenix and Tevard Biosciences to develop therapies for Dravet syndrome » 17:46
12/03/20
12/03
17:46
12/03/20
17:46
ZGNX

Zogenix

$22.07 /

+0.59 (+2.75%)

Zogenix and Tevard…

Zogenix and Tevard Biosciences, a privately-held biotechnology company pioneering tRNA-based gene therapies, a global biopharmaceutical company developing and commercializing rare disease therapies, have entered into a collaboration to identify and develop novel tRNA-based gene therapies for Dravet syndrome and other genetic epilepsies. Tevard will utilize its two unique tRNA-based discovery platforms focused on mRNA Stabilization and Nonsense Codon Suppression to discover and advance novel drug candidates for the treatment of Dravet syndrome and other genetic epilepsies. Zogenix will further develop the candidates through advanced preclinical studies and clinical development, and be responsible for worldwide commercialization. Zogenix is responsible for funding the collaboration and, under the terms of the agreement, Tevard will receive an initial collaboration payment of $10M, of which approximately $5M has previously been paid by Zogenix. Tevard will also receive $5M in the form of a convertible note. Tevard is also eligible to receive additional development, regulatory and commercial-related milestone payments ranging from $70M to $100M for each program, as well as tiered royalties on future net global sales on any commercial products that result from the collaboration.

ShowHide Related Items >><<
ZGNX Zogenix
$22.07 /

+0.59 (+2.75%)

ZGNX Zogenix
$22.07 /

+0.59 (+2.75%)

08/24/20 Raymond James
Zogenix initiated with a Market Perform at Raymond James
07/15/20 Stifel
Physician survey suggests Zogenix shares undervalued, says Stifel
06/29/20 Mizuho
Zogenix price target lowered to $55 from $64 at Mizuho
06/26/20 Stifel
FDA approval of Fintepla provides 'sigh of relief' for Zogenix, says Stifel
ZGNX Zogenix
$22.07 /

+0.59 (+2.75%)

  • 04
    Mar
ZGNX Zogenix
$22.07 /

+0.59 (+2.75%)

ZGNX Zogenix
$22.07 /

+0.59 (+2.75%)

ZGNX Zogenix
$22.07 /

+0.59 (+2.75%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.